-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, BoJO5j4hVMD0BPtR9CaRc10osMcMmsbspX8NDZNtgo8q9KSMrrmJUftdAyyjBkoH V4AabAme+GQ+eKBJKs8bzA== 0001209191-08-036493.txt : 20080611 0001209191-08-036493.hdr.sgml : 20080611 20080611173043 ACCESSION NUMBER: 0001209191-08-036493 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20080605 FILED AS OF DATE: 20080611 DATE AS OF CHANGE: 20080611 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: NOVEN PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000815838 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 592767632 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 11960 SW 144TH ST CITY: MIAMI STATE: FL ZIP: 33186 BUSINESS PHONE: 3052535099 MAIL ADDRESS: STREET 1: 11960 SW 144TH STREET CITY: MIAMI STATE: FL ZIP: 33185 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Gilbert Richard P. CENTRAL INDEX KEY: 0001437132 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 000-17254 FILM NUMBER: 08893979 BUSINESS ADDRESS: BUSINESS PHONE: 305-253-5099 MAIL ADDRESS: STREET 1: C/O NOVEN PHARMACEUTICALS, INC. STREET 2: 11960 S.W. 144TH STREET CITY: MIAMI STATE: FL ZIP: 33186 3 1 doc3.xml FORM 3 SUBMISSION X0202 3 2008-06-05 0 0000815838 NOVEN PHARMACEUTICALS INC NOVN 0001437132 Gilbert Richard P. C/O NOVEN PHARMACEUTICALS, INC. 11960 S.W. 144TH STREET MIAMI FL 33186 0 1 0 0 Vice President - Operations Employee Stock Option (Right to Buy) 16.35 2011-12-05 Common Stock ($.0001 par value) 30000 D Employee Stock Option (Right to Buy) 13.68 2012-11-14 Common Stock ($.0001 par value) 23191 D Stock Appreciation Right 22.83 2013-11-13 Common Stock ($.0001 par value) 19908 D Stock Appreciation Right 14.54 2014-11-12 Common Stock ($.0001 par value) 29806 D This option is currently fully vested and exercisable. 25% exercisable beginning on 11/15/2006; 25% exercisable beginning on 11/15/2007; 25% exercisable beginning on 11/15/2008; and 25% exercisable beginning on 11/15/2009. 25% exercisable beginning on 11/14/2007; 25% exercisable beginning on 11/14/2008; 25% exercisable beginning on 11/14/2009; and 25% exercisable beginning on 11/14/2010. 25% exercisable beginning on 11/13/2008; 25% exercisable beginning on 11/13/2009; 25% exercisable beginning on 11/13/2010; and 25% exercisable beginning on 11/13/2011. Mr. Gilbert was named an "executive officer" of Noven Pharmaceuticals, Inc. ("Noven") on June 5, 2008. The equity grants reported herein were previously made to Mr. Gilbert in connection with his prior and continued service to Noven as Vice President-Operations. /s/ Richard P. Gilbert 2008-06-11 -----END PRIVACY-ENHANCED MESSAGE-----